Pargluva Fluid Retention, Cardiac Risk To Be Central Issues At Advisory Committee
This article was originally published in The Pink Sheet Daily
Executive Summary
Data showing heart failure rates with 5 mg dose of muraglitazar may be higher than with 30 mg pioglitazone (Lilly/Takeda's Actos) in type 2 diabetes patients will be presented to committee at Sept. 9 review.